180 related articles for article (PubMed ID: 32384767)
1. Multi-Targeting Bioactive Compounds Extracted from Essential Oils as Kinase Inhibitors.
Maruca A; Lanzillotta D; Rocca R; Lupia A; Costa G; Catalano R; Moraca F; Gaudio E; Ortuso F; Artese A; Trapasso F; Alcaro S
Molecules; 2020 May; 25(9):. PubMed ID: 32384767
[TBL] [Abstract][Full Text] [Related]
2. Computational Evaluation and In Vitro Validation of New Epidermal Growth Factor Receptor Inhibitors.
Gómez-Ganau S; Castillo J; Cervantes A; de Julián-Ortiz JV; Gozalbes R
Curr Top Med Chem; 2020; 20(18):1628-1639. PubMed ID: 32493189
[TBL] [Abstract][Full Text] [Related]
3. Volatile Inhibitors of Phosphatidylinositol-3-Kinase (PI3K) Pathway: Anticancer Potential of Aroma Compounds of Plant Essential Oils.
Bordoloi M; Saikia S; Kolita B; Sarmah R; Roy S; Narzary B
Anticancer Agents Med Chem; 2018; 18(1):87-109. PubMed ID: 28356026
[TBL] [Abstract][Full Text] [Related]
4. Analyzing Kinase Similarity in Small Molecule and Protein Structural Space to Explore the Limits of Multi-Target Screening.
Schmidt D; Scharf MM; Sydow D; Aßmann E; Martí-Solano M; Keul M; Volkamer A; Kolb P
Molecules; 2021 Jan; 26(3):. PubMed ID: 33530327
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Oncogenic Kinases: An In Vitro Validated Computational Approach Identified Potential Multi-Target Anticancer Compounds.
Ikram N; Mirza MU; Vanmeert M; Froeyen M; Salo-Ahen OMH; Tahir M; Qazi A; Ahmad S
Biomolecules; 2019 Mar; 9(4):. PubMed ID: 30925835
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of novel 2,3-dihydropyrazino[1,2-a]indole-1,4-dione derivatives as antiproliferative EGFR and BRAF
Al-Wahaibi LH; Gouda AM; Abou-Ghadir OF; Salem OIA; Ali AT; Farghaly HS; Abdelrahman MH; Trembleau L; Abdu-Allah HHM; Youssif BGM
Bioorg Chem; 2020 Nov; 104():104260. PubMed ID: 32920363
[TBL] [Abstract][Full Text] [Related]
7. Essential oils as anticancer agents: Potential role in malignancies, drug delivery mechanisms, and immune system enhancement.
Sharma M; Grewal K; Jandrotia R; Batish DR; Singh HP; Kohli RK
Biomed Pharmacother; 2022 Feb; 146():112514. PubMed ID: 34963087
[TBL] [Abstract][Full Text] [Related]
8. Can structural features of kinase receptors provide clues on selectivity and inhibition? A molecular modeling study.
Ravichandran S; Luke BT; Collins JR
J Mol Graph Model; 2015 Apr; 57():36-48. PubMed ID: 25635590
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and in silico insights of new 7,8-disubstituted-1,3-dimethyl-1H-purine-2,6(3H,7H)-dione derivatives with potent anticancer and multi-kinase inhibitory activities.
Mohamed AR; El Kerdawy AM; George RF; Georgey HH; Abdel Gawad NM
Bioorg Chem; 2021 Feb; 107():104569. PubMed ID: 33387732
[TBL] [Abstract][Full Text] [Related]
10. Structure-Based Kinase Profiling To Understand the Polypharmacological Behavior of Therapeutic Molecules.
Dutta D; Das R; Mandal C; Mandal C
J Chem Inf Model; 2018 Jan; 58(1):68-89. PubMed ID: 29243930
[TBL] [Abstract][Full Text] [Related]
11. A New Series of Antileukemic Agents: Design, Synthesis, In Vitro and In Silico Evaluation of Thiazole-Based ABL1 Kinase Inhibitors.
Zeytün E; Altıntop MD; Sever B; Özdemir A; Ellakwa DE; Ocak Z; Ciftci HI; Otsuka M; Fujita M; Radwan MO
Anticancer Agents Med Chem; 2021; 21(9):1099-1109. PubMed ID: 32838725
[TBL] [Abstract][Full Text] [Related]
12. Enhanced antitumor potential induced by chloroacetate-loaded benzophenones acting as fused tubulin-pyruvate dehydrogenase kinase 1 (PDHK1) ligands.
Ghinet A; Thuru X; Floquet E; Dubois J; Farce A; Rigo B
Bioorg Chem; 2020 Mar; 96():103643. PubMed ID: 32035298
[TBL] [Abstract][Full Text] [Related]
13. QSAR based docking studies of marine algal anticancer compounds as inhibitors of protein kinase B (PKBβ).
Davis GD; Vasanthi AH
Eur J Pharm Sci; 2015 Aug; 76():110-8. PubMed ID: 25936945
[TBL] [Abstract][Full Text] [Related]
14. Discovery of new cyanopyridine/chalcone hybrids as dual inhibitors of EGFR/BRAF
Abou-Zied HA; Beshr EAM; Gomaa HAM; Mostafa YA; Youssif BGM; Hayallah AM; Abdel-Aziz M
Arch Pharm (Weinheim); 2023 Apr; 356(4):e2200464. PubMed ID: 36526595
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and Anti-Proliferative Evaluations of New Heterocyclic Derivatives Using 5,6,8,9-Tetrahydropyrazolo[5,1-b]quinazolin-7(3H)-one Derivatives Derived from Cyclohexa-1,4-dione.
Mahmoud MAA; Alsharif MA; Mohareb RM
Anticancer Agents Med Chem; 2021; 21(4):468-486. PubMed ID: 32445457
[TBL] [Abstract][Full Text] [Related]
16. New Approaches for the Synthesis of Heterocyclic Compounds Corporating Benzo[d]imidazole as Anticancer Agents, Tyrosine, Pim-1 Kinases Inhibitions and their PAINS Evaluations.
Mohareb RM; Milad YR; Mostafa BM; El-Ansary RA
Anticancer Agents Med Chem; 2021; 21(3):327-342. PubMed ID: 32698742
[TBL] [Abstract][Full Text] [Related]
17. Investigation of Crystal Structures in Structure-Based Virtual Screening for Protein Kinase Inhibitors.
Chen X; Liu H; Xie W; Yang Y; Wang Y; Fan Y; Hua Y; Zhu L; Zhao J; Lu T; Chen Y; Zhang Y
J Chem Inf Model; 2019 Dec; 59(12):5244-5262. PubMed ID: 31689093
[TBL] [Abstract][Full Text] [Related]
18. Virtual screening of B-Raf kinase inhibitors: A combination of pharmacophore modelling, molecular docking, 3D-QSAR model and binding free energy calculation studies.
Zhang W; Qiu KX; Yu F; Xie XG; Zhang SQ; Chen YJ; Xie HD
Comput Biol Chem; 2017 Oct; 70():186-190. PubMed ID: 28892749
[TBL] [Abstract][Full Text] [Related]
19.
Imana SN; Ningsih EG; Tambunan USF
Pak J Biol Sci; 2020 Mar; 23(4):567-574. PubMed ID: 32363843
[TBL] [Abstract][Full Text] [Related]
20. Integrating ligand-based and protein-centric virtual screening of kinase inhibitors using ensembles of multiple protein kinase genes and conformations.
Dixit A; Verkhivker GM
J Chem Inf Model; 2012 Oct; 52(10):2501-15. PubMed ID: 22992037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
